Role of genetic polymorphisms associated with lipid disorders and arterial hypertension in the assessment of clinical severity and in-hospital prognosis in patients with ST-segment elevation myocardial infarction

Role of genetic polymorphisms associated with lipid disorders and arterial hypertension in the assessment of clinical severity and in-hospital prognosis in patients with ST-segment elevation myocardial infarction

Objective: To study the clinical and prognostic significance of gene polymorphisms APOA1 rs670, APOA5 rs662799 and ACE rs4341 in patients with ST-segment elevation myocardial infarction. Materials and Methods: 358 patients admitted with STEMI and undergoing diagnosis and treatment at the Kemer...

Full description

Bibliographic Details
Main Authors:	A. A. Inozemtseva, V. V. Kashtalap, L. A. Gordeeva, E. N. Usoltseva, O. V. Gruzdeva, N. A. Terenteva, O. L. Barbarash
Format:	Article
Language:	Russian
Published:	Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics 2015-12-01
Series:	Атеросклероз
Subjects:	myocardial infarction genetic polymorphism prognosis lipid metabolism
Online Access:	https://ateroskleroz.elpub.ru/jour/article/view/777/715

Similar Items

ROLE OF THE SERUM NGAL FOR ASSESSMENT OF HOSPITAL PROGNOSIS IN MEN WITH ST ELEVATION MYOCARDIAL INFARCTION
by: V. N. Karetnikova, et al.
Published: (2015-06-01)

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

Galectin-3 – prospective biomarker of risk stratification in patients with ST-segment elevation myocardial infarction
by: N. V. Fedorova, et al.
Published: (2015-12-01)

Application of biological markers of kidney injury for prognosis of long-term adverse outcomes in patients with ST-segment elevation myocardial infarction
by: O. L. Barbarash, et al.
Published: (2014-09-01)

The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
by: V N Karetnikova, et al.
Published: (2016-06-01)

CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2015-11-01)

PROGNOSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION, IN REGARD TO THE PRESENCE OF TYPE 2 DIABETES MELLITUS AND SELECTED TREATMENT STRATEGY IN THE ACUTE PERIOD
by: Yu. A. Belen’kova, et al.
Published: (2012-10-01)

RESULTS OF ENDOVASCULAR REVASCULARIZATION IN ELDERLY PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION IN MULTIVESSEL DISEASE
by: A. M. Kochergina, et al.
Published: (2016-03-01)

Clinical significance and dynamics of biomarkers of myocardial remodeling in patients with ST segment elevation myocardial infarction and preserved left ventricular function
by: T. B. Pecherina, et al.
Published: (2018-03-01)

INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2011-12-01)

THE STUDY OF RS1800629 (G-308А) POLYMORPHISM OF THE TNF GENE IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ELEVATED ST SEGMENT
by: M. V. Zykov, et al.
Published: (2014-10-01)

CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-06-01)

SYNTAX residual in long-term outcomes prognosis of endovascular revascularization in myocardial infarction with ST elevation and multivessel disease
by: R. S. Tarasov, et al.
Published: (2016-10-01)

In-hospital outcomes of ST elevation myocardial infarction in post-COVID-19 patients
by: M. G. Chashchin, et al.
Published: (2023-03-01)

Pro-inflammatory cytokines and depression in myocardial infarction
by: O. L. Barbarash, et al.
Published: (2011-04-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

LIMITATIONS ON PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION IN THE CLINICAL PRACTICE
by: V. V. Kashtalap, et al.
Published: (2016-03-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry
by: D. Yu. Sedykh, et al.
Published: (2022-03-01)

Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01)

Genetic markers of risk for ST-elevated myocardial infarction
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS
by: M. V. Zykov, et al.
Published: (2012-02-01)

Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo)
by: D. Yu. Sedykh, et al.
Published: (2020-01-01)

LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
by: O. L. Barbarash, et al.
Published: (2017-05-01)

Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction
by: O V Gruzdeva, et al.
Published: (2016-04-01)

PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES
by: R. M. Magdeev, et al.
Published: (2016-01-01)

Comparison of Short Term In-Hospital Outcomes in patients presenting with ST-Elevation Myocardial Infarction Versus Non-ST-Elevation Myocardial Infarction
by: Masood Khan, et al.
Published: (2023-12-01)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

Long-term prognosis in patients with acute non-ST elevation myocardial infarction depending on dynamics of tissue myocardial dopplerography
by: Mikhail Yakovlevich Krasnosel'skiy, et al.
Published: (2011-09-01)

Socio-economic and behavioral «portrait» of patients with myocardial infarction
by: O. L. Barbarash, et al.
Published: (2022-07-01)

Significance of C-Reactive Protein in Patients with ST-Elevation Myocardial Infarction Over Non-ST-Elevation Myocardial Infarction
by: Shahzadi Anum, et al.
Published: (2023-01-01)

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

Thrombus aspiration in patients with ST-segment elevation myocardial infarction: a literature review
by: V. V. Ryabov, et al.
Published: (2023-09-01)

Relationship of ST-segment elevation myocardial infarction with weather and season
by: Okkes Zortuk, et al.
Published: (2024-04-01)

REGIONAL ALGORITHM OF CARE IN ST ELEVATION MYOCARDIAL INFARCTION
by: A. Yu. Vafin, et al.
Published: (2016-03-01)

Comorbidity in acute heart failure complicating myocardial infarction
by: M. V. Zykov, et al.
Published: (2020-08-01)

Impact of chronic obstructive pulmonary disease on one-year prognosis in patients with ST-segment elevation myocardial infarction
by: O M Polikutina, et al.
Published: (2015-09-01)

Strategies to Reduce the Door-to-Device time in ST-Elevation Myocardial Infarction Patients
by: Mojtaba Salarifar, et al.
Published: (2019-01-01)

IN-PATIENT OUTCOMES OF PHARMACOINVASIVE REPERFUSION STRATEGY FOR ST ELEVATION MYOCARDIAL INFARCTION
by: A. V. Khripun, et al.
Published: (2016-03-01)

ST-segment elevation myocardial infarction in the presence of metabolic-associated fatty liver disease
by: V. A. Tretyakova, et al.
Published: (2023-12-01)